At ArgoBio, we build the next generation of European biotech champions.

       
Argobio’s mission is to unlock Europe’s scientific potential and turn it into a sustainable pipeline of globally competitive biotech companies that improve patient outcomes and strengthen the European life sciences ecosystem.

We bridge the gap between science and venture investment
Argobio operates at the intersection of academia, venture capital, and pharma, transforming scientific discoveries into investable, de-risked opportunities. Our model turns early-stage science into “VC-ready” companies with validated technology, a clear development plan, and credible management from day one.

Argobio is an operational venture builder 
We go beyond funding. We co-found, invest in, and embed our experienced, collaborative team within each new company to accelerate  development with industrial rigor and speed toward value-creating milestones, reducing execution risk from the outset.

PORTFOLIO

Argobio has built a pipeline of projects
reflecting the diversity of therapeutic indications
and modalities of interest.